[Kamiya Biomedical] Boc-Asp-(Obzl)-Lys(Z)-OtBu, Reversin 121
Cat. No: BC-052 (5 mg)
Formula:
C34H47N3O9
Molecular Weight: 642
Description:
Selective high affinity inhibitor of Pgp (MDR1).
IC50 of Pgp-dependent Calcein-AM extrusion =
0.3 µM, IC50 of MRP1-dependent Calcein-AM
extrusion = 1.8 µM, EC50 for Pgp ATPase activity
= 0.2 µM.
Purity: ≥ 98%
Solubility:
Soluble in DMSO
Melting Point:
80-90°C
Format:
White to off-white powder
Storage and Stability:
Keep cool and dry at -20°C.
Caution / Handling:
Do not take internally. Wear gloves and mask
when handling this product. Avoid contact
by all modes of exposure.
If you are not fully trained or are unaware of
the hazards involved, do not use these
compounds.
Limitations:
For in vitro research use only. Not for use in
diagnostics or in humans.
Warranty:
No warranties, expressed or implied, are made
regarding the use of this product. KAMIYA
BIOMEDICAL COMPANY is not liable for any
damage, personal injury, or economic loss
caused by this product.
'Kamiya Biomedical' 카테고리의 다른 글
[Kamiya Biomedical] Human Anti-Interferon Gamma Antibody (Anti-IFNg) ELISA (0) | 2023.02.08 |
---|---|
[Kamiya Biomedical] Anti-AATF pAb (0) | 2020.12.02 |
[Kamiya Biomedical] Biotin-FA-FMK (Cathepsin B Inhibitor) (0) | 2020.08.07 |
[Kamiya Biomedical] Anti-E-tag (GAPVPYPDPLEPR) pAb (0) | 2020.06.09 |
[Kamiya Biomedical] Anti-8-Hydroxy-2’-deoxyguanosine (8-OHdG) mAb, clone N45.1 (0) | 2020.05.29 |